ROBAEYS, Geert

Full Name
ROBAEYS, Geert
Email
geert.robaeys@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Results 101-120 of 123 (Search time: 0.014 seconds).

Issue DateTitleContributor(s)TypeCat.
1012016Case Management to Improve Uptake for Screening and Therapy of Hepatitis C viral infection in People Who Inject Drugs.BIELEN, Rob; Verrando, Rita; PENDERS, Joris; Oris, Els; Nevens, Frederik; ROBAEYS, GeertJournal ContributionM
1022016Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugsARAIN, Amber; Bourgeois, S.; de Galocsy, C.; Henrion, J.; Deltenre, P.; d'Heygere, F.; George, C.; Bastens, B.; Van Overbeke, L.; Verrando, R.; BRUCKERS, Liesbeth; Mathei, Catharina; Buntinx, F.; Van Vlierberghe, H.; Francque, S.; Laleman, W.; Moreno, C.; Janssens, F.; Nevens, F.; ROBAEYS, GeertJournal ContributionA1
1032016Experience with Direct Acting Agents for the Treatment of Hepatitis C in Flanders.BIELEN, Rob; ROBAEYS, Geert; Cool, M.; Decaestecker, J.; Janssens, F.; George, C.; Laleman, W.; Verslype, C.; CASSIMAN, David; Van der Merwe, S.; Nevens, F.Conference MaterialC2
1042015Influence of the ethnic status in chronic hepatitis B patients: comparing the Netherlands, Belgium and TurkeyKOC, Ozgur; Konsten, Sarah; Jansen, Geraldine; ROBAEYS, Geert; Yildirim, Beytullah; Posthouwer, Dirk; Koek, Ger H.Journal ContributionM
1052015The modeled impact of improved Hepatitis C Virus (HCV) treatment strategies on HCV prevalence among people who inject drugs (PWIDs) in BelgiumMathei, Catharina; Bourgeois, Stefan; Brixko, Christian; Blach, Sarah; Mulkay, Jean-Pierre; Razavi, Homie; Serste, Thomas; ROBAEYS, GeertJournal ContributionM
1062015Recommendations for the management of hepatitis C virus infection among people who inject drugsGrebely, Jason; ROBAEYS, Geert; Bruggmann, Philip; Aghemo, Alessio; Backmund, Markus; Bruneau, Julie; Byrne, Jude; Dalgard, Olav; Feld, Jordan J.; Hellard, Margaret; Hickman, Matthew; Kautz, Achim; Litwin, Alain; Lloyd, Andrew R.; Mauss, Stefan; Prins, Maria; Swan, Tracy; Schaefer, Martin; Taylor, Lynn E.; Dore, Gregory J.Journal ContributionA2
1072015Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCD genotype 2/3 infection: the activate studyGrebely, J.; Dalgard, O.; Conway, B.; Foster, G.; Bruggmann, P.; Backmund, M.; ROBAEYS, Geert; Swan, T.; Hajarizadeh, B.; Amin, J.; Marks, P.; Quiene, S.; Weltman, M.; Shaw, D.; Dunlop, A.; Hellard, M.; Bruneau, J.; Bourgeois, S.; Thurnheer, C.; Dore, G. J.Journal ContributionM
82014Hepatitis C in European prisons: a call for an evidence-informed responseARAIN, Amber; ROBAEYS, Geert; Stöver, HeinoJournal ContributionA1
92014Eligibility of persons who inject drugs for treatment of hepatitis C virus infectionARAIN, Amber; ROBAEYS, GeertJournal ContributionA1
102013The Belgian experience in treatment of persons who used drugs with the new standard of care in genotype 1 HCV infected patients: an interim analysisARAIN, Amber; Bourgeois, Stefan; de Galocsy, Chantal; Deltenre, Pierre; D'Heygere, Francois G.; Georges, Christophe; Bastens, B.; Van Overbeke, Lode; Verrando, Rita; BRUCKERS, Liesbeth; Mathei, Catharina; Buntinx, Frank; Van Vlierberghe, Hans; Francque, Sven; Laleman, W.; Moreno, Christophe; ROBAEYS, GeertJournal ContributionM
112013Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject DrugsROBAEYS, Geert; Grebely, Jason; Mauss, Stefan; Bruggmann, Philip; Moussalli, Joseph; De Gottardi, Andrea; Swan, Tracy; ARAIN, Amber; Kautz, Achim; Stoever, Heino; Wedemeyer, Heiner; Schaefer, Martin; Taylor, Lynn; Backmund, Markus; Dalgard, Olav; Prins, Maria; Dore, Gregory J.Journal ContributionA1
122011Depressive symptoms following interferon-alpha therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?Kenis, Gunter; Prickaerts, Jos; van Os, Jim; Koek, Ger H.; ROBAEYS, Geert; STEINBUSCH, Harry; Wichers, MariekeJournal ContributionA1
132011Study protocol of KLIMOP: a cohort study on the wellbeing of older cancer patients in Belgium and the NetherlandsDeckx, Laura; van Abbema, Doris; NELISSEN, Katherine; Daniels, Liesbeth; STINISSEN, Piet; BULENS, Paul; LINSEN, Loes; RUMMENS, Jean-Luc; ROBAEYS, Geert; DE JONGE, Eric; HOUBEN, Bert; Pat, Karin; Walgraeve, Daan; Verheezen, Jolanda; Verniest, Thessa; Goegebuer, Alexander; Wildiers, Hans; van den Berkmortel, Franchette; Tjan-Heijnen, Vivianne C.; SPAAS, Luc; Buntinx, Frank; van den Akker, MarjanJournal ContributionA1
142009Previous Intravenous Substance Use and Outcome of Liver Transplantation in Patients With Chronic Hepatitis C InfectionROBAEYS, Geert; Nevens, F.; Starkel, P.; Colle, I.; Van Eyken, P.; BRUCKERS, Liesbeth; Van Ranst, M.; Buntinx, F.Proceedings PaperC1
152008Intravenous substance use and the outcome of liver transplantation for chronic hepatitis CROBAEYS, Geert; Nevens, F.; Van Eyken, P.; Starkel, P.; Colle, I.; BRUCKERS, Liesbeth; Van Ranst, M.; Buntinx, F.Journal ContributionM
162007Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisolWichers, M.C.; Kenis, G.; Koek, G.H.; ROBAEYS, Geert; Nicolson, N.A.; Maes, M.Journal ContributionA1
172007Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeksROBAEYS, Geert; De Bie, Jozef; Wichers, Marieke C.; BRUCKERS, Liesbeth; Nevens, F.; Michielsen, Peter; Van Ranst, M.; Buntinx, FrankJournal ContributionA1
182006Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causesROBAEYS, Geert; Van Vlierberghe, Hans; Mathei, Catharina; Van Ranst, Marc; BRUCKERS, Liesbeth; Buntinx, FrankJournal ContributionA1
192003Compliance and effect of treatment for chronic hepatitis C (CHC) in intravenous drug users (IVDUs)ROBAEYS, Geert; Van Vlierberghe, H; MATHEI, Steven; Van Ranst, M.; BRUCKERS, Liesbeth; Buntinx, FJournal ContributionM
202003Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trialVan Vlierberghe, H; Leroux-Roels, G; Adler, M.; Bourgeois, N; Horsmans, Y; Brouwer, J; Colle, I; Delwaide, J; Brenard, R; Bastens, B.; Henrion, J; de Vries, RA; de Galocsy, C; Michielsen, P; Nevens, Y.; ROBAEYS, Geert; BRUCKERS, LiesbethJournal ContributionA1